These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29091299)

  • 61. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatocyte-specific depletion of ubiquitin regulatory X domain containing protein 8 accelerates fibrosis in a mouse non-alcoholic steatohepatitis model.
    Imai N; Suzuki M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishigami M; Hirooka Y; Ishikawa T; Goto H; Fujimoto T
    Histochem Cell Biol; 2017 Sep; 148(3):219-227. PubMed ID: 28421320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Arid1a regulates insulin sensitivity and lipid metabolism.
    Qu YL; Deng CH; Luo Q; Shang XY; Wu JX; Shi Y; Wang L; Han ZG
    EBioMedicine; 2019 Apr; 42():481-493. PubMed ID: 30879920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.
    Zhao GN; Zhang P; Gong J; Zhang XJ; Wang PX; Yin M; Jiang Z; Shen LJ; Ji YX; Tong J; Wang Y; Wei QF; Wang Y; Zhu XY; Zhang X; Fang J; Xie Q; She ZG; Wang Z; Huang Z; Li H
    Nat Med; 2017 Jun; 23(6):742-752. PubMed ID: 28481357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.
    Liu C; Rajapakse AG; Riedo E; Fellay B; Bernhard MC; Montani JP; Yang Z; Ming XF
    Sci Rep; 2016 Feb; 6():20405. PubMed ID: 26846206
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
    Jiang W; Liu J; Dai Y; Zhou N; Ji C; Li X
    J Gastroenterol Hepatol; 2015 May; 30(5):933-43. PubMed ID: 25559563
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
    Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a.
    Wang S; Song K; Srivastava R; Dong C; Go GW; Li N; Iwakiri Y; Mani A
    FASEB J; 2015 Aug; 29(8):3436-45. PubMed ID: 25917329
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH; Luo WJ; Xu QY; Hua J
    World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease.
    Yan H; Gao Y; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):180-186. PubMed ID: 27909723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SHP-1 ameliorates nonalcoholic steatohepatitis by inhibiting proinflammatory cytokine production.
    Lin L; Jian J; Song CY; Chen F; Ding K; Xie WF; Hu PF
    FEBS Lett; 2020 Sep; 594(18):2965-2974. PubMed ID: 32619269
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Altenusin, a Nonsteroidal Microbial Metabolite, Attenuates Nonalcoholic Fatty Liver Disease by Activating the Farnesoid X Receptor.
    Zheng Z; Zhao Z; Li S; Lu X; Jiang M; Lin J; An Y; Xie Y; Xu M; Shen W; Guo GL; Huang Y; Li S; Zhang X; Xie W
    Mol Pharmacol; 2017 Oct; 92(4):425-436. PubMed ID: 28739572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.
    Park H; Liu Y; Kim HS; Shin JH
    Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3.
    Wang J; Guo Y; He Y; Qin Y; Li X; Yang L; Liu K; Xiao L
    Mol Metab; 2024 Feb; 80():101882. PubMed ID: 38237897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway.
    Xie L; Chen C; Zhang T; Yang W; Zheng D; Cao L; Yuan J; Xu Y; Zhang Y; Liu L; Liang A; Yu Z; Zheng J
    Cell Death Dis; 2024 Jul; 15(7):515. PubMed ID: 39025844
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model.
    Hou J; Chen Y; Cai Z; Heo GS; Yuede CM; Wang Z; Lin K; Saadi F; Trsan T; Nguyen AT; Constantopoulos E; Larsen RA; Zhu Y; Wagner ND; McLaughlin N; Kuang XC; Barrow AD; Li D; Zhou Y; Wang S; Gilfillan S; Gross ML; Brioschi S; Liu Y; Holtzman DM; Colonna M
    Sci Transl Med; 2024 Apr; 16(741):eadj9052. PubMed ID: 38569016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
    Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
    Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.